Oncology Firm Develops Test for Potential Pediatric Cancers Diagnoses
Share Article
Modern cancer diagnosis tests and treatments are based on what works for adults. A new technology, NV-VPAC1(™), may help doctors better and more accurately diagnose childhood cancers, according to developer NuView Life Sciences.
Last year, the National Cancer Institute estimated that over 11,000 new cancer cases would be diagnosed in American children.
Pediatric cancers are now more treatable than before. At the moment, we are trying to avoid late effects.
PARK CITY, Utah (PRWEB)
February 08, 2021
Last year, the National Cancer Institute estimated that over 11,000 new cancer cases would be diagnosed in American children.(1) In most cases, doctors don’t know what causes childhood cancers—unlike adults, children haven’t been exposed to various cancer-causing substances over a long period of time, and they also aren’t subject to the effects of aging on the body which may result in cancer in adults. Only about 5% of pediatric cancers are linked to specific genetic mutations which are inherited from a child’s parents.(1) While the American Cancer Society estimates that up to 84% of children with cancer will survive for five years or longer as a result of current treatments,(2) there is still a need for better pediatric diagnostic and treatment options.